(marketscreener.com) AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference. The live presentation and Q&A session, which will occur virtually, will take place on January 12,...https://www.marketscreener.com/news/latest/AavantiBio-to-Present-at-the-40th-Annual-J-P-Morgan-Healthcare-Conference--37460819/?utm_medium=RSS&utm_content=20220104
AavantiBio is a Massachusetts-based biotechnology company that develops gene therapies for the treatment of cardiac and central nervous system dysfunctions.